Larimar Therapeutics (LRMR) Treasury Shares (2013 - 2025)
Larimar Therapeutics (LRMR) posted Treasury Shares of $1.0 million for Q4 2025, up 400.26% on a QoQ basis from $200000.0 in Q3 2025, and up 43.14% year-over-year from $699003.0 in Q4 2024.
Larimar Therapeutics (LRMR) Treasury Shares (2013 - 2025) Analysis & Trends
Larimar Therapeutics' Treasury Shares history runs 5 years deep, the most recent figure standing at $1.0 million for Q4 2025.
- Quarterly Treasury Shares rose 43.14% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (up 43.14% YoY) and the FY2025 annual result came in at $1.0 million, up 43.14% from the prior year.
- Treasury Shares was $1.0 million for Q4 2025 at Larimar Therapeutics, up from $200000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.0 million in Q1 2025 and bottomed at $200000.0 in Q2 2025.
- A 3-year average of $645872.2 and a median of $672501.5 in 2023 frame the typical range for Treasury Shares.
- Peak annual rise in Treasury Shares reached 44.78% in 2025, while the deepest fall reached 71.44% in 2025.
- Larimar Therapeutics' Treasury Shares stood at $615000.0 in 2023, then gained by 13.66% to $699003.0 in 2024, then surged by 43.14% to $1.0 million in 2025.
- Business Quant data shows LRMR's Treasury Shares at $1.0 million in Q4 2025, $200000.0 in Q3 2025, and $200000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 5.14 Mn |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.00 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 1.02 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 699,003.00 |
| Dec 31, 2024 | 699,003.00 |
| Sep 30, 2024 | 699,003.00 |
| Sep 30, 2024 | 699,003.00 |
| Jun 30, 2024 | 700,259.00 |
| Jun 30, 2024 | 700,259.00 |
| Mar 31, 2024 | 706,622.00 |
| Mar 31, 2024 | 706,622.00 |
| Dec 31, 2023 | 615,000.00 |
| Dec 31, 2023 | 615,000.00 |
| Sep 30, 2023 | 615,000.00 |
| Sep 30, 2023 | 615,000.00 |